The first medical device to treat ADHD has been approved by the U.S. Food and Drug Administration for marketing by the device maker, NeuroSigma, Inc.
The Monarch external Trigeminal Nerve Stimulation (eTNS) System will be available, by prescription only, to… Read the rest
As we’ve blogged about in the past, teen drivers with ADHD are a risk on the road. Studies have found that inexperience, coupled with inattention and poor judgment are a dangerous mix when kids with ADHD get behind the wheel.… Read the rest
If you follow the news at all, you’re aware of the growing scandal surrounding college admissions: a number of wealthy parents are allegedly complicit in using bribery to facilitate acceptance of their sons and daughters to elite colleges. One of… Read the rest
The move to push school start times back may finally be gaining national momentum.
Despite years of research showing the benefits to adolescents of starting school at 8:30 instead of 7:30, along with the full-throated support from sleep experts and… Read the rest
In one of the few long-term studies on the prevalence of ADHD in the US, researchers at the University of Iowa recently found the number of diagnosed cases of ADHD has increased significantly during the past 20 years—from 6.1% to… Read the rest